SCHEMBL6062895

SCHEMBL6062895

O=C(O)N(CCS(=O)(=O)Cc1ccccc1)C(=O)NC1(C(=O)c2nc3ccccc3o2)CCC1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
FAAH O00519 2/20 0.36
CES1 P23141 1/20 0.36
DAGLA Q9Y4D2 1/20 0.36
XDH P47989 4/20 0.36
KDM4E B2RXH2 2/20 0.35
RAB9A P51151 2/20 0.35
GLO1 Q04760 1/20 0.35
POLB P06746 1/20 0.34
CTSS P25774 2/20 0.33
MAPK1 P28482 1/20 0.33
CHRNA7 P36544 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.32
SLC12A2 P55011 1/20 0.32
SLC12A5 Q9H2X9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7042183 0.89 ALDH1A1 (0.37) ALDH1A1FAAHCES1DAGLAXDH
SCHEMBL6061798 0.85 RAB9A (0.32) XDHKDM4ERAB9AGLO1CTSS
SCHEMBL6462784 0.83 FAAH (0.37) FAAHCES1DAGLAXDHKDM4E
SCHEMBL6062899 0.77 FAAH (0.37) ALDH1A1FAAHCES1DAGLAXDH
SCHEMBL7043387 0.76 XDH (0.31) XDH
SCHEMBL6464410 0.75 FAAH (0.42) ALDH1A1FAAHCES1DAGLACTSS
SCHEMBL6468436 0.75 CTSS (0.44) ALDH1A1XDHCTSS
SCHEMBL6464424 0.74 CTSS (0.43) ALDH1A1XDHCTSS
SCHEMBL6464404 0.73 DAGLA (0.48) ALDH1A1FAAHCES1DAGLAXDH
SCHEMBL7044364 0.73 XDH (0.35) ALDH1A1FAAHCES1DAGLAXDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1694357-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2006-08-30 EP disclosed
WO-2005058348-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2005-06-30 WO disclosed
EP-1516877-A1 Amine derivatives as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2005-03-23 EP disclosed